you may be right, but its kind of on a knife edge with this all UK or nothing strategy (they are hoping to maintain to be a number 3? so at best getting potentially zip revenues 50m to 100m, by when in another year?). The issue is this would be fine in a vacuum and not observing their competitors, how they compare against theirs competitors matter and will become harder when they wish to expand to other markets as being too slow to land grab is a BAD idea (eg they failed in aus because of too much competition). I think most bought in thinking this would be a fast growth stock but seems it may be a slow burn that will grow along with revenue. However not focusing on US also is a really bad move as once the opportunity for US is lost the stock is toast.
- Forums
- ASX - By Stock
- LBY
- Ann: Laybuy Market Update
Ann: Laybuy Market Update, page-38
-
-
- There are more pages in this discussion • 103 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LBY (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online